Michel Laroche. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultBone Density Conservation Agents/administration & dosageBone Diseases, Metabolic/drug therapyBone Diseases, Metabolic/etiologyBone Diseases, Metabolic/physiopathologyFemaleFractures, Bone/drug therapyFractures, Bone/etiologyFractures, Bone/physiopathologyHumansHypophosphatasia/complicationsHypophosphatasia/geneticsHypophosphatasia/physiopathologyTeriparatide/administration & dosageTreatment Failure
Substances: See more » Bone Density Conservation AgentsTeriparatide
Year: 2012 PMID: 22218563 DOI: 10.1007/s00223-011-9562-5
Source DB: PubMed Journal: Calcif Tissue Int ISSN: 0171-967X Impact factor: 4.333